News
MKGAF
159.71
NaN%
--
Weekly Report: what happened at MKGAF last week (0601-0605)?
Weekly Report · 1d ago
Weekly Report: what happened at MKGAF last week (0525-0529)?
Weekly Report · 06/01 09:33
Weekly Report: what happened at MKGAF last week (0518-0522)?
Weekly Report · 05/25 09:34
Weekly Report: what happened at MKGAF last week (0511-0515)?
Weekly Report · 05/18 09:34
Merck KGaA reports Q1 results
Seeking Alpha · 05/13 10:46
Stock Index Futures Gain as Tech Stocks Rebound, U.S. PPI Data and Trump-Xi Summit in Focus
Barchart · 05/13 05:31
Here are the major earnings before the open Wednesday
Seeking Alpha · 05/12 22:00
Weekly Report: what happened at MKGAF last week (0504-0508)?
Weekly Report · 05/11 09:33
Weekly Report: what happened at MKGAF last week (0427-0501)?
Weekly Report · 05/04 09:32
Elizabeth Warren Calls Trump's '600%' Drug Price Claim Mathematically Impossible: 'His Promise Is As Empty As…'
Benzinga · 04/30 08:43
Weekly Report: what happened at MKGAF last week (0420-0424)?
Weekly Report · 04/27 09:33
Merck KGaA: Small Breakout In 2026, Followed By Normalization
Seeking Alpha · 04/27 01:48
Inhibrx cancer drug reportedly drawing interest of Merck and rivals
Seeking Alpha · 04/22 12:37
Weekly Report: what happened at MKGAF last week (0413-0417)?
Weekly Report · 04/20 09:32
Weekly Report: what happened at MKGAF last week (0406-0410)?
Weekly Report · 04/13 09:33
Weekly Report: what happened at MKGAF last week (0330-0403)?
Weekly Report · 04/06 09:33
Weekly Report: what happened at MKGAF last week (0323-0327)?
Weekly Report · 03/30 09:33
Abivax CEO suggests no urgency for deal-making ahead of key trial readout
Seeking Alpha · 03/24 17:04
Weekly Report: what happened at MKGAF last week (0316-0320)?
Weekly Report · 03/23 09:32
U.S. starts seeking drugmakers’ views in turning Trump's pricing deals into law
Seeking Alpha · 03/20 12:38
More
Webull provides a variety of real-time MKGAF stock news. You can receive the latest news about Merck through multiple platforms. This information may help you make smarter investment decisions.
About MKGAF
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business segment is operating in the therapeutic areas of oncology, neurology & immunology and fertility as well as cardiovascular, metabolic and endocrinological disorders. The Life Sciences segment is operating with its three business units such as, Science & Lab Solutions, Process Solutions and Life Science Services. It is also a supplier of products, tools and services for research laboratories, pharmaceutical and biopharmaceutical production as well as industrial and testing laboratories. The Electronics business segment consists of the Semiconductor Solutions, Display Solutions and Surface Solutions business units. Its Semiconductor Solutions business unit consists of the thin films, formulations, specialty gases, and delivery systems & services business fields.